Industry Disruptor
Abio Technologies leads the field of stem cell and exosome science as Korea's first human stem cell culture facility. For over 18 years, Abio produced and supplied high-quality stem cell products using independently developed media. Our commitment to innovation is evident in our leading patented Exotraction™ technology, which enables mass production and purification of highest-purity exosomes. |
Unparalleled R&D
With 33 patents for advanced technology and established state-of-the-art smart farm cultivation facilities, Abio also operates Korea's largest freeze-drying plant, ensuring the preservation of product quality. Abio's FDA, EU, and KFDA authorizations, along with full compliance with KFDA human stem cell and tissue culture media safety standards, guarantee reliable, safe, and stable products. |